Therapeutic strategies to boost levels of the protective antiproteases such as A1AT in the lungs remain a potentially attractive approach to protect the lungs from the damage caused by excess proteases in patients with CF [6]. The gene discussed is SERPINA1; the disease is cystic fibrosis.